Community Advisory Board

Readers Rep

Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

350.29 +4.37 (+1.26%)

Streaming Delayed Price Updated: 3:17 PM EDT, Apr 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

65 66 Next >

Where Will Amgen Be in 3 Years? ↗

May 29, 2024

The Amgen of 2027 could be much be larger than some investors expect.

Via The Motley Fool

OZEM ETF: 7 Things to Know About the New Roundhill GLP-1 & Weight Loss ETF ↗

May 28, 2024

As weight loss drugs are gaining popularity Roundhill GLP 1 And Weight Loss ETF (OZEM) has launched as anew way to invest in them.

Via InvestorPlace

Topics ETFs

Amgen's Catching Up to Novo Nordisk and Eli Lilly. Should You Buy It? ↗

May 26, 2024

The gold rush for obesity medications just got a bit more intense.

Via The Motley Fool

What's Going On With Mid-Cap Cancer-Focused Verastem Oncology Stock On Friday? ↗

May 24, 2024

Verastem Oncology reports promising initial results from the RAMP 205 trial with an 83% ORR for avutometinib and defactinib in metastatic pancreatic cancer. FDA submission for recurrent KRAS mutant...

Via Benzinga

Stocks to Buy: 7 Undeniable Dow Darlings to Pile Into Now ↗

May 24, 2024

Most Dow stocks are strong investments but these 7 stand out at the moment as the macroenvironment trends positive again.

Via InvestorPlace

Topics Stocks

If You Invested $1000 In This Stock 20 Years Ago, You Would Have $5,700 Today ↗

May 21, 2024

Via Benzinga

Amgen Unusual Options Activity ↗

May 17, 2024

Via Benzinga

Market Whales and Their Recent Bets on AMGN Options ↗

May 08, 2024

Via Benzinga

EXCLUSIVE: Roundhill Investments Launches Weight Loss ETF For Exposure To Blockbuster Drugs Like Ozempic ↗

May 21, 2024

Roundhill CEO Dave Mazza says investors "can't just buy a basket of big pharma names or a broad-based biotech ETF and call it a day."

Via Benzinga

Topics ETFs

7 Reliable Blue-Chip Stocks That Cannot Miss ↗

May 21, 2024

These reliable blue-chip stocks to own are the closest thing to slam dunk investments that exist. Discover why you should buy them now.

Via InvestorPlace

Amgen/AstraZeneca Say Asthma Drug Shows Activity In Another Lung Disease Across Broad Patient Population ↗

May 20, 2024

Amgen and AstraZeneca reveal Phase 2a results for Tezspire in severe COPD, showing a 17% reduction in exacerbations, with notable improvements in lung function and quality of life for patients with...

Via Benzinga

7 Biotech Stocks That Could Breathe New Life Into Your Portfolio ↗

May 20, 2024

Thanks to the underlying pertinence, these established biotech stocks to buy offer confidence to investors facing tricky market conditions.

Via InvestorPlace

How Is The Market Feeling About Amgen? ↗

May 07, 2024

Via Benzinga

Dow Jones Industrial Average Closes Above 40,000 In Quiet Friday Climb ↗

May 19, 2024

The Dow Jones Industrial Average closed above the 40,000.00 major handle for the first time ever after markets wound down a hectic trading week that saw rate cut hopes return to the forefront after US...

Via Talk Markets

Topics Economy Stocks

Is Amgen a Threat to Eli Lilly in This Billion-Dollar Market? ↗

May 19, 2024

Eli Lilly's biggest growth drivers today are its weight loss drugs.

Via The Motley Fool

Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch ↗

May 18, 2024

President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA).

Via Benzinga

Topics Cannabis

Pharma Stocks Outlook: Where Are 2024’s Top Performers Headed Next? ↗

May 17, 2024

Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason.

Via InvestorPlace

FDA Gives Accelerated Approval To Amgen's Drug For Small Cell Lung Cancer Patients ↗

May 17, 2024

FDA approves Amgen's Imdelltra for treating ES-SCLC, based on response rate and DoR in clinical studies. Approval may depend on further trials.

Via Benzinga

Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk ↗

May 17, 2024

Could Amgen be the next stock to soar due to a GLP-1 drug?

Via The Motley Fool

S&P 500, Nasdaq 100, Dow Jones Shatter Record Highs In Unstoppable Bull Market Rally ↗

May 15, 2024

The S&P 500, Nasdaq 100 and Dow Jones Industrial Average indices all shattered fresh all-time highs Wednesday, driven by a benign inflation report that boosted risk sentiment among bullish investors.

Via Benzinga

Topics Economy Stocks

The 3 Best Dow Stocks to Buy in May 2024 ↗

May 13, 2024

The Dow Jones Industrial Average has been on a hot streak this month. Here are the three best Dow stocks to buy.

Via InvestorPlace

Topics Stocks

Amgen Is Working On a Wegovy Competitor -- What It Means for Investors ↗

May 12, 2024

The biotech's pipeline extends far beyond this exciting weight-loss product.

Via The Motley Fool

5 Stocks Driving Dow's Market-Beating Performance ↗

May 11, 2024

While 27 of the 30 members of the Dow Jones Index have performed well over the last seven days, we have highlighted five of them that have been leading the way higher.

Via Talk Markets

Topics Stocks

7 Weight Loss Drug Stocks Poised for Explosive Growth by 2025 ↗

May 09, 2024

The second wave of the weight loss drug stock boom is underway and investors should heed the signs the market is serving.

Via InvestorPlace

Trade Desk To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Thursday ↗

May 09, 2024

Via Benzinga

Wall Street Stares At Weaker Open On Rate Anxiety, Hopes For Better Earnings: Analyst Pencils Key S&P 500 Support Level ↗

May 09, 2024

Trading in U.S. index futures suggests stocks may be off to a lackluster start again on Thursday.

Via Benzinga

Topics Stocks

Sector Superstars: 3 Stocks Generating the Most Buzz on Wall Street ↗

May 09, 2024

Discover the reasons behind three stocks attracting investor attention as they stand on the precipice of future growth.

Via InvestorPlace

Dow Jones Industrial Average Pushes Higher On Wednesday Despite Tepid Risk Appetite ↗

May 08, 2024

Via Talk Markets

Topics Stocks

3 Tried and True Dividend Stocks to Buy for Your Portfolio ↗

May 07, 2024

These dividend stocks to buy represent time-tested companies with significant growth potential. Dive in now to strengthen your portfolio.

Via InvestorPlace

The Option Market Shows The Way Through This Low-Volume, Fed-Driven Melt-Up ↗

May 06, 2024

The S&P 500 ended today’s session a little more than 1% higher than where it started. At the same time, trading volume in equities has been very light.

Via Talk Markets

Topics Stocks

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

65 66 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

About Us

Amgen (NQ:AMGN)

All News about Amgen